AlphaCentric Advisors’s Alkermes ALKS Stock Holding History

AlphaCentric Advisors’s Portfolio ALKS Stock Details ALKS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-42,500	Closed	-$1.19M	–	223
2023 Q3	$1.19M	Buy	42,500 +7,500	+21%	+$220K	0.68%	49
2023 Q2	$1.1M	Sell	35,000 -10,000	-22%	-$303K	0.61%	61
2023 Q1	$1.27M	Buy	+45,000	New	+$1.23M	0.88%	34

Other funds holding ALKS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

HJGA

Hardman Johnston Global Advisors Stamford, Connecticut $2.85B AUM 35.77% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AlphaCentric Advisors's ALKS Position: Q4 2023 in Review

AlphaCentric Advisors sold out of Alkermes (ALKS) in Q4 2023, closing a stake of 42,500 shares — an estimated $1.19M sold.

AlphaCentric Advisors first reported a position in ALKS in Q1 2023 and held it in 3 quarters. The position peaked at $1.27M in Q1 2023. 301 funds tracked by Wall St. Rank hold ALKS as of Q4 2023.

AlphaCentric Advisors reported no remaining Alkermes position as of Q4 2023 after selling out during the quarter.
AlphaCentric Advisors sold 42,500 Alkermes shares in Q4 2023, an estimated $1.19M.
AlphaCentric Advisors first reported a position in Alkermes in Q1 2023 and held it in 3 quarters.
AlphaCentric Advisors's Alkermes position peaked at $1.27M in Q1 2023.
301 funds tracked by Wall St. Rank held Alkermes as of Q4 2023.

Based on AlphaCentric Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.